Bevacizumab-based first-line chemotherapy in elderly patients with metastatic colorectal cancer: an individual patient data based meta-analysis.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/29130

Title:	Bevacizumab-based first-line chemotherapy in elderly patients with metastatic colorectal cancer: an individual patient data based meta-analysis.
Authors:	Koch, Christine Schwing, Anna M Herrmann, Eva Borner, Markus Diaz-Rubio, Eduardo Dotan, Efrat Feliu, Jaime Okita, Natsuko Souglakos, John Arkenau, Hendrik T Porschen, Rainer Koopman, Miriam Punt, Cornelis J A de Gramont, Aimery Tournigand, Christophe Zeuzem, Stefan Trojan, Joerg View more
Keywords:	bevacizumab elderly first-line chemotherapy metastatic colorectal cancer View more
Issue Date:	13-Feb-2018
Citation:	Oncotarget.2018 Feb;(9)12:10272-10283
Abstract:	The aim of this meta-analysis was to evaluate efficacy and safety of first-line chemotherapy with or without a monoclonal antibody in elderly patients (≥ 70 years) with metastatic colorectal cancer (mCRC), since they are frequently underrepresented in clinical trials.
PMID:	29535805
URI:	https://hdl.handle.net/20.500.12530/29130
Rights:	openAccess
Appears in Collections:	Hospitales > H. U. Clínico San Carlos > Artículos Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos Hospitales > H. U. La Paz > Artículos

Files in This Item:

File	Description	Size	Format
PMC5828201.pdf		2.74 MB	Adobe PDF	View/Open